您现在的位置: 首页> 研究主题> 肝样细胞

肝样细胞

肝样细胞的相关文献在2005年到2021年内共计83篇,主要集中在基础医学、内科学、细胞生物学 等领域,其中期刊论文71篇、会议论文1篇、专利文献145728篇;相关期刊33种,包括中华细胞与干细胞杂志(电子版)、健康之路、基础医学与临床等; 相关会议1种,包括第18次全国干扰素及细胞因子学术会议等;肝样细胞的相关文献由277位作者贡献,包括范敬静、吴玉卓、李东良等。

肝样细胞—发文量

期刊论文>

论文:71 占比:0.05%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:145728 占比:99.95%

总计:145800篇

肝样细胞—发文趋势图

肝样细胞

-研究学者

  • 范敬静
  • 吴玉卓
  • 李东良
  • 李程
  • 陈红
  • 高毅
  • 丁建强
  • 丰慧根
  • 何秀华
  • 侯艳宁
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 纳涛; 孙懿; 吴婷婷; 欧阳琦; 卢光琇; 林戈; 袁宝珠
    • 摘要: 肝细胞、肝组织或器官移植是目前不可逆失代偿性肝病的主要治疗手段,而由人胚胎干细胞诱导分化来源的肝样细胞(human embryonic stem cells-derived hepatocyte-like cells,hESC-HLCs)能为移植提供数量充足、质量可控、来源稳定的细胞.为满足临床应用研究的需要,hESC-HLCs需具备明确的基本生物学属性、微生物学安全性、生物学安全性及生物学有效性的总体质量要求,其中每一类质量要求是由多个关键质量属性所组成.hESC-HLCs的整个制备过程是从人胚胎干细胞(hESCs)向hESC-HLCs的全分化过程,可基本分为4个阶段,各阶段在细胞形态、标志基因/蛋白的表达、生物学功能等方面均有明显的特征.本文就hESC-HLCs总体质量要求及各质量属性进行讨论,目的是在我国建立临床研究用hESC-HLCs质量评价方法和评价策略.
    • 于云宝1**; 林芷伊2; 满洋1; 苗章1; 朱东阳1; 张宏伟1***; 彭心宇1***
    • 摘要: 目的:探讨内皮前体细胞(endothelial precursor cells,EPCs)在间充质干细胞(mesenchymal stem cells,MSCs)向肝样细胞转化中的作用.方法:分离培养SD大鼠MSCs和EPCs,取第3代MSCs向肝样细胞转化培养,培养过EPCs的无血清及因子的培养基(endothelial progenitor cell-conditioned medium,EPCs-CM)、无血清的α-最低必需培养基(alpha minimal essential medium,α-MEM)分别与肝细胞转化培养基按1:1比例配置,作为实验组和模型对照组,正常α-MEM培养基为空白对照组,分别观察细胞形态及数量变化;在培养3、5、7、9 d时应用免疫荧光检测甲胎蛋白(alpha fetoprotein,AFP)、清蛋白(albumin,ALB)的表达.结果:空白对照组MSCs形态无明显变化;实验组与模型对照组细胞均出现肝样细胞形态.空白对照组未见AFP、ALB表达,模型对照组和实验组在3、5、7、9 d AFP、ALB表达水平均增高,其中实验组比模型对照组AFP、ALB水平增高明显.结论:EPCs在MSCs向肝样细胞转化中可能起一定的促进作用.
    • 李淑华; 高丽莲; 陈系古; 付强; 张齐好
    • 摘要: 目的:探讨悬滴培养诱导稳定表达人肝细胞生长因子(hHGF)的大鼠骨髓间充质干细胞(rMSCs)向肝样细胞分化的效应.方法:体外分离和培养rMSCs,采用流式细胞术检测干细胞表面标志分子CD44、CD90、CD34和CD45的表达率;构建重组逆转录病毒表达载体pLNCX2-hHGF,包装病毒感染rMSCs,获得稳定表达hHGF的细胞株hHGF-rMSCs;分别对rMSCs和hHGF-rMSCs进行悬滴培养,在培养第7、14和21天,通过RT-qPCR和免疫荧光技术检测白蛋白(ALB)、甲胎蛋白(APF)和角蛋白18(CK-18)在mRNA和蛋白水平上的表达,此外,还利用ELISA的方法检测培养液上清中ALB的分泌.结果:第3代rMSCs高表达CD44和CD90,几乎不表达CD34和CD45;构建表达载体后,成功建立了hHGF-rMSCs细胞株,且经过悬滴培养后,在第7~21天都呈现ALB、AFP和CK-18在mRNA水平上的高表达(P<0.01);免疫荧光结果显示,AFP蛋白在第21天出现阳性表达,而ALB和CK-18蛋白在第7天就呈现阳性表达;在第7~21天,ELISA法均检测到hHGF-rMSCs细胞培养上清中ALB的分泌增多(P<0.01).结论:将HGF基因导入rMSCs,经悬滴培养可诱导分化为肝样细胞,可能为临床肝脏疾病的细胞治疗和体外生物人工肝提供新型种子细胞.
    • 谭铭辉; 梁宇灵; 黄文斌; 程远; 蒋泽生; 何国林; 高毅; 潘明新
    • 摘要: 目的 探索应用Galectin-3诱导大鼠骨髓间充质干细胞分化为肝样细胞的效果,筛选出所涉及的信号通路,并验证Hippo信号通路.方法 对大鼠股骨骨髓间充质干细胞进行提取、分离、传代培养及鉴定.取第3代细胞进行诱导培养,分为SD大鼠BMSCs(A组)、SD大鼠BMSCs+0.5μg/mL Gal-3(B组)、SD大鼠BMSCs+20 ng/mL HGF(C组)、SD大鼠BMSCs+0.5μg/mL Gal-3+20 ng/mL HGF(D组)和大鼠肝细胞(E组).分别在诱导后7、14、21、28 d进行细胞形态学观察、糖原染色观察,并行实时定量PCR以及Western blot检测,鉴定其分化情况.取B组细胞行基因芯片检测.将BMSCs与Gal-3、Gal-3+XMU-MP-1(Hippo信号通路抑制剂)分组进行诱导,Western Blot检测YAP、P-YAP、ALB、AFP、CK-18.结果 大鼠股骨骨髓分离出的细胞符合骨髓间充质干细胞特性.诱导后,B、C、D组BMSCs形态逐渐向肝样细胞转化,D组28 d时细胞形态与肝细胞相对比相似度最高.糖原染色28 d时A组无染色,B、C、D组染色较前增多,B、C组间无明显差异(P>0.05),D组染色率最高(P<0.05).Q-PCR检测AFP、ALB、CK-18表达逐渐升高,28 d时B组与C组各指标较接近(P<0.05).Gal-3与HGF对AFP、ALB的mRNA表达不存在交互效应(AFP:F=0.236,P=0.640;ALB:F=50.639,P=0.000),对CK-18的mRNA表达有协同效应(F=50.639,P=0.000).Western blot检测A组几乎不表达AFP、ALB及CK18,B、C、D组AFP、ALB及CK18蛋白表达随时间延长,逐渐增加.基因芯片检测发现上调基因27个,下调基因62个.涉及TGF-β、PI3K-Akt及Hippo等信号通路.Gal-3及Gal-3+XMU-MP-1诱导组的YAP表达较空白对照组增加,Gal-3+XMU-MP-1较单独应用Gal-3诱导BMSCs分化的效率高.结论 Galectin-3能够单独诱导骨髓间充质干细胞向肝样细胞分化,而且联合HGF诱导BMSCs分化的效率更高.诱导过程与TGF-β、PI3K-Akt及Hippo等信号通路相关.抑制Hippo信号通路可提高诱导效率.
    • 姜华; 高建鹏; 王辉; 张志波
    • 摘要: 目的 探寻大鼠骨髓间充质干细胞(mesenchymal stem cells,MSCs)分化成肝细胞过程中的核心调控机制.方法 利用芯片检测结果,筛选大鼠骨髓MSCs诱导分化成肝细胞样细胞(hepatocytelike cells,HLCs)、正常肝细胞(normal liver cells,NLCs)动态发展过程中差异表达的基因,利用基因的表达变化进行表达趋势聚类,筛选出显著性的表达趋势.集中分析具有相同趋势的共表达基因,构建基因的共表达调控网络,从中筛选在动态变化过程中的核心基因.结果 从MSCs分化成NLCs的动态过程中,通过筛选得到4 938个差异表达基因,Fas、G6pc、IL1b、S100a1、Ndufa7等基因为关键基因.结论 MSCs最终分化成NLCs的过程中,与细胞周期调控、增殖、分化相关基因及糖、脂肪酸、胆固醇的代谢、解毒相关基因表达密切相关.%Objective To explore the possible mechanism of the central regulatory mechanism from rat bone marrow mesenchymal stem cells (BMSCs) differentiated into hepatocytes.Methods Differentially expressed genes in the dynamic development process of BMSCs differentiated into hepatocyte like cells (ALCs) and normal liver cells (NLCs) were screened.Expression trends by gene expression changes were clustered and a significant trend of expression was screened out.The co-expression genes with the same trend were analyzed,co-expression regulatory network of genes was constructed.Core genes in dynamic change process were screened.Results In the dynamic process from BMSCs differentiated into NLCs,4 938 differentially expressed genes were screened out.Fas,G6pc,IL1b,S100a1,Ndufa7 and other genes were the key genes.Conclusion In the process of BMSCs eventually differentiated into NLCs,BMSCs is closely related to cell cycle regulation,proliferation,differentiation and related genes,sugar,fatty acids,cholesterol metabolism,detoxification related gene expression.
    • 彭琴; 尹燕峰; 管峥; 吕莎; 苏文君; 闪海燕; 张蕾
    • 摘要: BACKGROUND:Umbilical cord mesenchymal stem cells can be induced to differentiate into hepatocyte-like cells in vitro and in vivo.However,the exact mechanism is still unknown. Existing studies have shown that the Wnt/β-catenin signaling pathway is closely related to this process. OBJECTIVE: To explore the effect of Wnt/β-catenin signaling pathway on the differentiation of umbilical cord mesenchymal stem cells into hepatocyte-like cells and its potential molecular mechanism. METHODS: Human umbilical cord mesenchymal stem cells were extracted from the neonatal umbilical cord by tissue adherent method. After being cultured and purified, the umbilical cord mesenchymal stem cells at passages 4-6 were divided into four groups: control group (DMEM culture group), hepatocyte-like differentiation group, activator Wnt3a group (adding 20 μg/L Wnt3a, an activator of Wnt/β-catenin signaling pathway, under the differentiation condition), and inhibitor Dkk-1 group (adding 20 μg/L Dkk-1, an inhibitor of Wnt/β-catenin signaling pathway, under the differentiation condition). Induced cells were collected respectively on days 7, 14, 21, 28. Their mRNA and protein expressions of α-fetoprotein (AFP), albumin (ALB), hepatocyte nuclear factor 4α (HNF4α) and Cytokeratin-19 (CK-19) in the cells were detected by real-time quantitative PCR and western blot respectively. Meanwhile, Periodic Acid-Schiff staining, low-density lipoprotein uptake test and indocyanine green absorption test were applied to detect the function of hepatocyte-like cells. RESULTS AND CONCLUSION: Compared with the control group, expressions of AFP and HNF4α mRNA and protein as well as ALB mRNA were significantly up-regulated in the hepatocyte-like differentiation group, activator Wnt3a group and inhibitor Dkk-1 group (P < 0.05). Whereas, there was a decrease in the CK-19 expression at mRNA and protein levels (P < 0.01) in these three groups. Compared with the hepatocyte-like differentiation group, the mRNA and protein expressions of AFP and HNF4α, and the mRNA expression of ALB were significantly down-regulated in the activator Wnt3a group (P < 0.05). Compared with hepatocyte-like differentiation group and activator Wnt3a group, the inhibitor Dkk-1 group had higher expression of AFP, HNF4α mRNA and their proteins as well as the mRNA expression of ALB (P <0.05). Findings from the Periodic Acid-Schiff staining, low-density lipoprotein uptake test and indocyanine green absorption test showed more positive cells in the inhibitor Dkk-1 group than in the hepatocyte-like differentiation group and least positive cells in the activator Wnt3a group. Overall, these findings suggest that the inhibition of Wnt/β-catenin signaling pathway promotes the differentiation of umbilical cord mesenchymal stem cells into hepatocyte-like cells;conversely,the cell differentiation can be inhibited via the Wnt/β-catenin pathway.%背景:脐带间充质干细胞可在体内外诱导分化为肝样细胞,然而确切机制目前尚不清楚,研究表明Wnt/β-catenin信号通路与之密切相关.目的:探讨Wnt/β-catenin信号通路对脐带间充质干细胞肝向分化的影响及其机制.方法:采用组织块贴壁法分离培养人脐带间充质干细胞,将培养至第4-6代脐带间充质干细胞分成4组,分别为对照组,常规诱导肝向分化组,激活剂Wnt3a组(在常规诱导肝向分化基础上加入20 μg/L Wnt/β-catenin信号通路激活剂Wnt3a),抑制剂Dkk-1组(在常规诱导肝向分化基础上加入20 μg/L Wnt/β-catenin信号通路抑制剂Dkk-1).分别在诱导第7,14,21,28天收集细胞,采用荧光定量PCR和Western blot检测肝细胞分化相关基因的mRNA和蛋白表达.运用PAS染色、LDL摄取实验、ICG吸收实验在诱导第28天时进行肝样细胞功能检测.结果与结论:①与对照组相比,常规诱导组、激活剂Wnt3a组、抑制剂Dkk-1组中除了CK-19 mRNA及蛋白表达均下调外(P < 0.01),AFP、ALB、HNF4α mRNA和AFP、HNF4α蛋白表达均显著上调(P < 0.05);②与常规诱导组相比,激活剂Wnt3a组AFP、ALB、HNF4α mRNA及AFP、HNF4α蛋白表达均显著下调(P < 0.05);③与常规诱导组、激活剂Wnt3a组相比,抑制剂Dkk-1组AFP、ALB、HNF4α mRNA及AFP、HNF4α蛋白表达显著增高(P < 0.05);④抑制剂Dkk-1组PAS染色、LDL摄取实验、ICG吸收实验中检测到的阳性细胞最多,常规诱导组其次,阳性细胞最少的是激活剂Wnt3a组;⑤以上结果表明,Wnt/β-catenin信号通路受抑制时可促进脐带间充质干细胞肝向分化,反之,则抑制脐带间充质干细胞肝向分化.
    • 陈嘉成; 傅念; 黄幼姣; 全宏军
    • 摘要: 骨髓干细胞包括造血干细胞(HSCs)和间充质干细胞(MSCs),骨髓间充质干细胞(BMSCs)是一类具有自我更新、增殖和多向分化能力的细胞,具有不对称分裂和无限增殖的特点.在肝细胞生长因子(HGF)的作用下,BMSCs可以分化为肝细胞,参与诱导这一分化过程的相关信号通路包括NF-kB信号通路、Notch信号通路、MAPK信号通路、Wnt信号通路和STAT3信号通路.文章主要就BMSCs分化为肝细胞的相关信号通路进行了综述.%Bone marrow stem cells include hematopoietic stem cells and mesenehymal stem cells.Bone marrow mesenchymal stem cells (BMSCs) are a kind of cells with properties of self-renewal,proliferation and multi-directional differentiation,and have the characteristic of asymmetric cell division and unlimited proliferation.Under the influences of hepatocyte growth factor (HGF),BMSCs can differentiate into liver cells,and related signaling pathways involved in the differentiation process include NF-kB signal pathways,Notch signal pathways,MAPK signal pathways,Wnt signal pathways and STAT3 signal pathways.The related signaling pathways of BMSCs differentiation into hepatocytes are reviewed in this article.
    • 彭琴12; 尹燕峰2; 管峥2; 吕莎2; 苏文君2; 闪海燕12; 张蕾2
    • 摘要: 背景:脐带间充质干细胞可在体内外诱导分化为肝样细胞,然而确切机制目前尚不清楚,研究表明Wnt/β-catenin信号通路与之密切相关.目的:探讨Wnt/β-catenin信号通路对脐带间充质干细胞肝向分化的影响及其机制.方法:采用组织块贴壁法分离培养人脐带间充质干细胞,将培养至第4-6代脐带间充质干细胞分成4组,分别为对照组,常规诱导肝向分化组,激活剂Wnt3a组(在常规诱导肝向分化基础上加入20 μg/L Wnt/β-catenin信号通路激活剂Wnt3a),抑制剂Dkk-1组(在常规诱导肝向分化基础上加入20 μg/L Wnt/β-catenin信号通路抑制剂Dkk-1).分别在诱导第7,14,21,28天收集细胞,采用荧光定量PCR和Western blot检测肝细胞分化相关基因的mRNA和蛋白表达.运用PAS染色、LDL摄取实验、ICG吸收实验在诱导第28天时进行肝样细胞功能检测.结果与结论:①与对照组相比,常规诱导组、激活剂Wnt3a组、抑制剂Dkk-1组中除了CK-19 mRNA及蛋白表达均下调外(P 〈 0.01),AFP、ALB、HNF4α mRNA和AFP、HNF4α蛋白表达均显著上调(P 〈 0.05);②与常规诱导组相比,激活剂Wnt3a组AFP、ALB、HNF4α mRNA及AFP、HNF4α蛋白表达均显著下调(P 〈 0.05);③与常规诱导组、激活剂Wnt3a组相比,抑制剂Dkk-1组AFP、ALB、HNF4α mRNA及AFP、HNF4α蛋白表达显著增高(P 〈 0.05);④抑制剂Dkk-1组PAS染色、LDL摄取实验、ICG吸收实验中检测到的阳性细胞最多,常规诱导组其次,阳性细胞最少的是激活剂Wnt3a组;⑤以上结果表明,Wnt/β-catenin信号通路受抑制时可促进脐带间充质干细胞肝向分化,反之,则抑制脐带间充质干细胞肝向分化.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号